Cibc World Market Inc. Takes $788,000 Position in Revvity Inc. $RVTY

Cibc World Market Inc. bought a new stake in shares of Revvity Inc. (NYSE:RVTY) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 8,986 shares of the company’s stock, valued at approximately $788,000.

A number of other large investors have also bought and sold shares of RVTY. CYBER HORNET ETFs LLC bought a new stake in Revvity in the second quarter valued at $32,000. MUFG Securities EMEA plc acquired a new stake in shares of Revvity in the 2nd quarter valued at about $34,000. CVA Family Office LLC increased its position in Revvity by 79.0% in the 2nd quarter. CVA Family Office LLC now owns 410 shares of the company’s stock valued at $40,000 after buying an additional 181 shares in the last quarter. Headlands Technologies LLC bought a new stake in Revvity in the 2nd quarter valued at about $49,000. Finally, Smartleaf Asset Management LLC raised its stake in Revvity by 56.8% during the 3rd quarter. Smartleaf Asset Management LLC now owns 690 shares of the company’s stock worth $58,000 after buying an additional 250 shares during the period. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Revvity Stock Down 1.2%

RVTY opened at $94.90 on Wednesday. Revvity Inc. has a fifty-two week low of $81.36 and a fifty-two week high of $120.39. The firm has a market capitalization of $10.76 billion, a P/E ratio of 45.63, a PEG ratio of 2.04 and a beta of 1.07. The company’s 50-day moving average is $103.41 and its 200 day moving average is $95.90. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.68 and a quick ratio of 1.40.

Revvity (NYSE:RVTY) last issued its quarterly earnings data on Monday, February 2nd. The company reported $1.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.15. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The business had revenue of $772.06 million during the quarter, compared to the consensus estimate of $759.81 million. During the same period in the prior year, the firm posted $1.42 EPS. The firm’s quarterly revenue was up 5.9% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. Research analysts expect that Revvity Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Friday, April 17th will be given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Friday, April 17th. Revvity’s dividend payout ratio (DPR) is presently 13.46%.

Revvity announced that its board has approved a share buyback program on Monday, October 27th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the company to purchase up to 8.7% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s board of directors believes its stock is undervalued.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. TD Cowen restated a “hold” rating on shares of Revvity in a report on Tuesday, February 3rd. The Goldman Sachs Group initiated coverage on shares of Revvity in a research note on Tuesday, December 9th. They set a “neutral” rating and a $105.00 price target for the company. Barclays raised their price objective on shares of Revvity from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Tuesday, February 3rd. Bank of America downgraded shares of Revvity from a “buy” rating to a “neutral” rating and set a $110.00 target price for the company. in a research report on Monday, December 15th. Finally, Robert W. Baird set a $129.00 target price on shares of Revvity in a report on Tuesday, February 3rd. Five equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $113.67.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.